CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 2,000 shares at an average $50.87 ($101,730)
- 4 Open-market sale Chief Executive Officer sold 3,000 shares at $50.02 ($150,060)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 2,036 shares at an average $47.10 ($95,885)
- 4 Open-market sale Chief Executive Officer sold 3,000 shares at $50.06 ($150,180)
- 4 Open-market buy 10% owner bought 624,575 shares at $49.50 ($30,916,463)
- 4 Open-market sale Director sold 5,090 shares at an average $54.37 ($276,753)
- 4 Open-market sale Chief Scientific Officer sold 2,146 shares at $58.03 ($124,532)
- 4 Open-market sale Chief Executive Officer sold 3,000 shares at $58.62 ($175,860)
- 4 Open-market sale Director sold 2,036 shares at an average $53.11 ($108,132)
- 4 Open-market sale Chief Scientific Officer sold 6,438 shares at $55.00 ($354,090)
- 4 Open-market sale Director sold 40,599 shares at an average $50.84 ($2,064,209)
- 4 Open-market sale Chief Executive Officer sold 3,000 shares at $50.47 ($151,410)
- 4 Open-market sale Director sold 243,082 shares at an average $49.36 ($11,997,896)
- 4 Open-market sale Director sold 135,364 shares at an average $49.37 ($6,683,464)
Page 25 of 38 · 758 filings